Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.?
- PMID: 17199818
- DOI: 10.1111/j.1748-720X.2006.00096.x
Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.?
Abstract
The main value of carrier detection in the general population is to determine reproductive risks. In this manuscript I examine the practice of providing carrier screening programs in the school setting. While the data show that high school screening programs can achieve high uptake, I argue that this may reflect a lack of full understanding about risks, benefits, and alternatives, and the right not to know. It may also reflect the inherent coercion in group testing, particularly for adolescents who are prone to peer pressure. The problem of carrier screening in the schools is compounded when the condition has a predilection for certain groups based on race, ethnicity or religion. I examine programs around the world that seek to test high school students for Tay Sachs and Cystic Fibrosis carrier status. I argue that carrier programs should be designed so as to minimize stigma and to allow individuals to refuse. The mandatory school environment cannot achieve this. Rather, I conclude that screening programs should be designed to attract young adults and not adolescents to participate in a more voluntary venue.
Similar articles
-
Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.Am J Med Genet. 1993 Aug 15;47(2):213-5. doi: 10.1002/ajmg.1320470214. Am J Med Genet. 1993. PMID: 8213907
-
Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.Med J Aust. 2012 Dec 10;197(11):652-4. doi: 10.5694/mja12.11010. Med J Aust. 2012. PMID: 23230938
-
Population screening for reproductive risk for single gene disorders in Australia: now and the future.Twin Res Hum Genet. 2008 Aug;11(4):422-30. doi: 10.1375/twin.11.4.422. Twin Res Hum Genet. 2008. PMID: 18637742
-
[Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease].Harefuah. 1995 Dec 1;129(11):475-80. Harefuah. 1995. PMID: 8846957 Review. Hebrew. No abstract available.
-
Population programs for the detection of couples at risk for severe monogenic genetic diseases.Hum Genet. 2009 Aug;126(2):247-53. doi: 10.1007/s00439-009-0669-y. Epub 2009 Apr 24. Hum Genet. 2009. PMID: 19390864 Review.
Cited by
-
Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.Genet Med. 2010 Apr;12(4 Suppl):S5-S14. doi: 10.1097/GIM.0b013e3181d5a669. Genet Med. 2010. PMID: 20393311 Free PMC article.
-
Carrier detection in childhood: a need for policy reform.Genome Med. 2010 Apr 22;2(4):25. doi: 10.1186/gm146. Genome Med. 2010. PMID: 20416117 Free PMC article.
-
A targeted population carrier screening program for severe and frequent genetic diseases in Israel.Eur J Hum Genet. 2009 May;17(5):591-7. doi: 10.1038/ejhg.2008.241. Epub 2008 Dec 24. Eur J Hum Genet. 2009. PMID: 19107146 Free PMC article.
-
Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.J Community Genet. 2014 Jan;5(1):13-29. doi: 10.1007/s12687-012-0131-z. Epub 2012 Dec 29. J Community Genet. 2014. PMID: 23275180 Free PMC article.
-
High school Tay-Sachs disease carrier screening: 5 to 11-year follow-up.J Community Genet. 2014 Apr;5(2):139-46. doi: 10.1007/s12687-013-0163-z. Epub 2013 Jul 27. J Community Genet. 2014. PMID: 23893770 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical